Antimicrobial Therapy for Infections Caused by Carbapenem-Resistant Gram-Negative Bacteria / 대한내과학회지
Korean Journal of Medicine
; : 439-446, 2018.
Article
在 Ko
| WPRIM
| ID: wpr-717699
Responsible library:
WPRO
ABSTRACT
Carbapenem-resistance emerging in Gram-negative pathogens, such as Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii, has become a major human health problem globally. The therapeutic options available for carbapenem-resistant pathogens are very limited. Antibiotics such as colistin, tigecycline, fosfomycin, and aminoglycosides are often the only ones that can be used to treat carbapenem-resistant pathogens. Carbapenem may still be an option in certain circumstances. The administration of combination therapy for carbapenem-resistant pathogens is controversial. This review presents the current knowledge of available antimicrobial therapeutic options for infections due to carbapenem-resistant pathogens in Korea.
Key words
全文:
1
索引:
WPRIM
主要主题:
Pseudomonas aeruginosa
/
Drug Resistance
/
Treatment Outcome
/
Colistin
/
Acinetobacter baumannii
/
Fosfomycin
/
Gram-Negative Bacteria
/
Aminoglycosides
/
Klebsiella pneumoniae
/
Korea
限制:
Humans
国家/地区名称主题:
Asia
语言:
Ko
期刊:
Korean Journal of Medicine
年:
2018
类型:
Article